QOL of Asian patients with IBD at presentation has not been studied. Aim: This study evaluates the QOL of IBD patients at diagnosis from an inception cohort across eight countries in Asia. Methods: Health-related QOL was measured by the validated IBD Questionnaire (IBDQ) in patients with newly diagnosed IBD between 2011 and 2012. Disease activity was assessed by the Simple Clinical this website Colitis Activity Index and Harvey-Bradshaw index for ulcerative
colitis (UC) and Crohn’s disease (CD), respectively. Demographic and disease characteristics were recorded. Results: 284 incident IBD cases (CD 93; UC 147; IC 14) were included. Median age was 37 (IQR: 26–49). Median duration from symptom onset to diagnosis GSK1120212 supplier was 6 months (IQR:2–24). Overall mean IBDQ score was 159 ± SEM 2.2 (Remission: IBQ≥170). The median IBDQ Score of South Asians (Thailand, Malaysia, Indonesia, Sri Lanka) (150; IQR:117–181) was significantly lower than the Han Chinese (Mainland China, Hong Kong, Singapore, Macau) (167; IQR:139–190; p = 0.003). IBD patients with active disease had significantly lower scores for all 4 dimensions of IBDQ (bowel, systemic, emotional and social functions) compared with those in remission (p < 0.001).
Multiple regression analyses identified only disease activity index to be associated with variations in QOL (p < 0.001). There was no significant difference in QOL between patients with CD, UC or IC (p = 0.403). QOL was not significantly affected by disease behavior for CD (B1, B2, B3, or perianal) but worsened with increasing mucosal involvement in UC (extensive > distal > proctitis; p = 0.014).
QOL score was not affected by employment status, education level or smoking history. Conclusion: QOL is impaired in newly diagnosed IBD patients, and varies across ethnic groups in Asia. Active disease 上海皓元 and more extensive disease are associated with worse QOL in IBD. Key Word(s): 1. Quality of life; 2. IBD; 3. Crohn’s disease; 4. ulcerative colitis; Presenting Author: ZHI TAO CHEN Additional Authors: JIE WU Corresponding Author: ZHI TAO CHEN Affiliations: The Central Hospital of Wuhan Objective: Our aim was to evaluate protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene polymorphisms in ulcerative colitis (UC) and explore PTPN22 mRNA levels in colonic biopsies of UC patients in central China. Methods: A total of 165 Chinese UC patients and 300 healthy controls were enrolled in this study. PTPN22 −1123G/C, +1858C/T and +788G/A polymorphisms were genotyped by PCR-restriction fragment length polymorphism method.
Related posts:
- In the Asian-Pacific area, Australia has the highest prevalence o
- There were 44 patients with biopsy-proven NASH
- Study Asks Adolescents With Inflammatory Bowel Disease About Use of CAM Mind-Body Therapies
- Survival of pomalidomide-treated PMF patients was compared to other PMF patients
- Specifically, there were IL-6 + macrophages and neutrophils ( Fig